Peterson Partners Raises $510 Million Continuation Vehicle for Kelso Industries: What the Deal Reveals About GP-Led Secondaries

TL;DR: On September 9, 2026, Peterson Partners closed a $510 million capital raise for Peterson Kelso Coinvest, LP, a single-asset continuation vehicle holding Kelso Industries, a national mechanical, electrical, and plumbing contractor. NorthSands Capital, founded in 2023 exclusively to invest in single-asset continuation vehicles, committed more than $450 million as sole lead investor. Full details are in the official announcement via PR Newswire.

The Deal: What Peterson Partners Did and Why

Peterson Partners backed Kelso Industries in 2021, partnering with co-founders Steve Carroll and Steve Nicholson to build a national MEP services platform. Five years later, Kelso employs more than 4,000 people across more than 40 states and serves data centers, hospitals, airports, industrial facilities, and advanced manufacturing sites. Peterson held the position across two funds: Fund VIII, an older vintage whose LPs were waiting for liquidity, and Fund X, the firm's current flagship.

An outright sale would have closed the chapter on one of Peterson's better-performing builds at a time when the firm believes the best returns still lie ahead. The continuation vehicle threaded that needle. Existing LPs in Fund VIII and Fund X got a binary choice: take cash at today's valuation, or roll their interest into the new vehicle. Fund X rolled its existing position and made an additional investment on top, signaling that Peterson's own team is putting fresh capital behind its conviction.

The raise closed at $510 million, with NorthSands Capital committing more than $450 million as sole lead investor. Jefferies LLC served as exclusive financial advisor to Peterson. Mayer Brown and Honigman LLP handled legal work for Peterson and Kelso. Kirkland and Ellis LLP represented NorthSands.

What a Single-Asset Continuation Vehicle Actually Is

A single-asset continuation vehicle is a separately managed fund created by a private equity general partner to hold one specific portfolio company past the original fund's planned exit horizon. The GP transfers the target asset from the existing fund into the new vehicle at an agreed valuation. LPs in the original fund then face a binary election: sell their interest at the CV valuation for cash, or contribute their interest into the new vehicle and maintain exposure to the company under the same manager.

New investors, referred to as CV investors, provide fresh capital to fund the transaction and support future growth. The GP continues managing the company under the new vehicle's terms. Critically, the GP's economics reset at the CV entry price: a new management fee schedule begins and carried interest is calculated from the new valuation, not the original fund's cost basis.

These transactions have moved from niche to mainstream. According to a July 2026 analysis by Mayer Brown, the secondary market reached approximately $240 billion in total volume in 2025, with GP-led transactions accounting for 48 percent of that total. Continuation vehicles made up between 86 and 89 percent of GP-led activity, and single-asset CVs accounted for 53 percent of CV volume within the GP-led segment. Industry projections suggest 30 to 40 percent of all private equity exits in 2026 and 2027 could take this form. This is a standard portfolio management mechanism, not a workaround deployed by struggling funds.

Why Peterson Chose a CV Instead of Selling Kelso Outright

Spencer Clawson, Partner at Peterson Partners, said Kelso "remains in the early innings of a significant opportunity." That language tells you exactly why Peterson did not sell: it believes the best returns are still ahead, and it wants to keep running and earning carried interest on this business rather than ceding it to a buyer at today's price.

Three practical reasons reinforce that logic. First, selling today forfeits future upside on an asset Peterson knows far better than any incoming buyer. Second, the CV structure lets new capital enter at a market-validated price on a platform with five years of demonstrated execution. Third, a CV centered on a single committed lead investor can close faster and with less management disruption than a competitive auction requiring broad market exposure and heavy due diligence from Kelso's leadership team.

The Structural Conflict: The GP Is on Both Sides of This Trade

I want to be direct about this, because it is the most important structural fact in any GP-led continuation vehicle and is often obscured in deal announcements.

Peterson is simultaneously the seller and the ongoing manager. As the general partner of Fund VIII and Fund X, Peterson is transferring Kelso out of those funds on behalf of LPs who invested in them. At the same time, Peterson is the general partner of the new continuation vehicle that is buying Kelso. Peterson sets the timing of the transaction, selects the reference valuation date, structures its own fee and carried interest economics in the new vehicle, and continues managing the company after closing. A lower CV valuation makes the new carry easier to earn because the hurdle in the new vehicle starts from a lower base. The GP also generates a fresh management fee stream that would not exist if the asset were sold outright.

As Proskauer Rose explained in its February 2026 analysis of a Delaware Court of Chancery challenge to a GP-led CV, the SEC has for many years flagged adviser-led secondaries as a review priority because "the adviser is effectively on both sides of the transaction and often stands to benefit from extended fees or a reset carried interest." A sovereign wealth fund's legal challenge to a separate GP-led CV in late 2025, which delayed that deal's close and drew public scrutiny, showed that sophisticated LPs are no longer letting process failures pass quietly.

The conflict cannot be eliminated by disclosure alone. What responsible governance requires is full and transparent disclosure, structural safeguards such as independent limited partner advisory committee review, and pricing through a genuine arm's-length market mechanism. In the Peterson-Kelso transaction, that market mechanism is NorthSands.

Why NorthSands Capital Is the Crucial Piece of This Structure

NorthSands Capital was founded in 2023 by Bruce McEvoy, a former Senior Managing Director in Blackstone's private equity business, around a single thesis: invest exclusively in single-asset continuation vehicles for middle market companies. NorthSands does not run a traditional buyout fund or do platform acquisitions. Its entire business model is built on pricing GP-led single-asset CVs as a distinct asset class.

That specialization matters here in two specific ways. First, NorthSands is functioning as the genuine market in this transaction. Its commitment of more than $450 million at the agreed valuation represents a real third-party, arm's-length price signal from an investor with no prior obligation to Peterson and no relationship with the old fund structure. NorthSands' returns depend entirely on getting CV valuations right. A firm that overpays consistently for CV assets does not stay in business. Its decision to commit $450 million at this price is therefore structurally more credible than a fairness opinion from an investment bank that also wants to win Peterson's next mandate.

Second, NorthSands' existence tells you where the market has gone. In 2023, someone with Blackstone credentials concluded that single-asset CVs would generate enough deal flow to support a dedicated underwriting firm. The Institutional Limited Partners Association published a standardized CV Disclosure Template in January 2026 and proposed updated guidance in June 2026, as Mayer Brown's July 2026 process analysis documents. A sub-industry now exists to structure, price, govern, and when necessary challenge these transactions. The single-asset CV is a recognized asset class, not an improvised exit tool.

What LPs Must Understand Before Deciding to Roll

If you are a limited partner in Peterson Fund VIII or Fund X, the election you face deserves careful analysis. Rolling into Peterson Kelso Coinvest, LP is not the same as continuing to hold your existing position. You are entering a new fund at a new price, under a new fee structure, with the GP's carried interest recalibrated to the CV's entry valuation. Any appreciation baked into the CV entry price becomes the new baseline. The GP earns its next tranche of carry from that baseline, not from your original cost in Fund VIII or Fund X.

The Willkie Farr and Gallagher analysis of SEC rules for GP-led secondaries, published in September 2023, put the conflict plainly: the sponsor is on both the buy-side and sell-side of a transaction involving fund investments sold from one adviser-managed client to a continuation vehicle managed by the same adviser. The SEC's August 2023 rules originally required an independent fairness or valuation opinion for these transactions. The Fifth Circuit vacated those rules in June 2024, but the fiduciary obligations under the Investment Advisers Act remain fully operative regardless.

NorthSands' lead commitment is a meaningful price check, but three questions are worth asking before you decide. What reference date was used to set the CV valuation, and has the business's performance shifted since then? What are the management fee and carry terms in the new vehicle compared with your existing fund documents? And did Peterson evaluate a full competitive sale process before proposing the CV? The Private Equity Law Report noted in a March 2025 analysis by Willkie attorneys that the SEC's 2025 examination priorities explicitly emphasized ensuring advisers adequately mitigate and disclose conflicts of interest in these structures, and that regulatory focus will continue regardless of administration changes.

The Bottom Line

The Peterson-Kelso continuation vehicle has the elements of a well-structured deal. Kelso is a genuine high-performer: a national MEP platform built from scratch in five years, serving structurally growing end markets with more than 4,000 employees and a demonstrated acquisition track record. The lead investor is a specialist whose business model depends entirely on accurate CV pricing. Peterson Fund X made an additional fresh investment alongside the roll, which is a direct signal that the GP believes in the valuation it negotiated with NorthSands.

At $510 million, this deal sits at the larger end of the lower-middle-market spectrum. NorthSands, built by a former Blackstone Senior MD, committed $450 million-plus with no incentive to overpay. That is meaningful institutional validation.

GP-led single-asset continuation vehicles are now a standard feature of private equity, not an exception. If you are an LP in Fund VIII or Fund X, treat the election as the real investment decision it is. Read the disclosure materials. Ask about the economic terms. Understand what you are buying at the CV price, not just what you have been holding in the old fund. The structure is more mature and better governed than it was three years ago. That does not mean you should skip the diligence.

Frequently Asked Questions

What is a single-asset continuation vehicle in private equity?

A single-asset continuation vehicle is a new, separately managed fund created by a private equity general partner to hold one specific portfolio company beyond the original fund's planned exit window. Existing limited partners can take cash at the current valuation or roll their interest into the new vehicle, while new investors provide fresh capital to fund the transaction and support the company's continued growth under the same manager.

Why would a GP choose a continuation vehicle over selling the portfolio company outright?

A GP typically chooses a continuation vehicle when it believes the portfolio company still has substantial unrealized upside that a sale at today's price would sacrifice. The structure lets the GP provide liquidity to limited partners who need it now, attract new capital at a market-validated price, and continue managing a company it knows well, without being forced to sell into conditions that may not reflect long-term value.

How does an independent lead investor reduce the conflict of interest in a GP-led continuation vehicle?

An independent lead investor such as NorthSands Capital negotiates the continuation vehicle's valuation at arm's length, with no prior obligation to the GP and no incentive to overpay. Because a specialist CV investor's own returns depend entirely on accurate pricing, its commitment at a specific valuation is a market-clearing signal that investment bank fairness opinions cannot replicate. The conflict is reduced but not eliminated, and LP advisory committee review remains important.

What risks do limited partners face when they elect to roll into a continuation vehicle?

Limited partners who roll are making a fresh investment at a new price in a new fund, not passively holding their prior position. The GP's carried interest resets at the CV valuation, so carry is earned from the new baseline rather than from the original fund cost basis. The rolled position also carries concentrated single-asset risk, compared with the diversification of a multi-company blind-pool fund.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.